LAGWX | Developing Growth Fund Class A | Lord Abbett

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

 

Developing Growth Fund

Track this Fund
Add to Hypo Tool

Summary

Summary

What is the Developing Growth Fund?

The Fund seeks to deliver long-term growth of capital by investing primarily in stocks of small U.S. companies.

Fund Basicsas of 08/31/2023

Total Net Assets
$2.53 B
Inception Date
10/10/1973
Dividend Frequency
Annually
Fund Gross Expense Ratio
0.94%
Fund Net Expense Ratio
0.94%
Number of Holdings
88
Minimum Initial Investment
$1,000+

Fund Expense Ratio :

Gross 0.94%

Net 0.94%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 10/10/1973
w/o sales charge 5.49% -3.09% -4.92% 2.53% 8.04% 10.26%
Lipper Category Avg. Small-Cap Growth Funds 11.58% 6.74% 3.41% 4.51% 8.90% -
Russell 2000® Growth Index 12.68% 6.78% 2.67% 2.46% 8.17% -
w/ sales charge -0.56% -8.68% -6.79% 1.33% 7.40% 10.13%

Fund Expense Ratio :

Gross 0.94%

Net 0.94%

Fund Expense Ratio :

Gross 0.94%

Net 0.94%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 10/10/1973
w/o sales charge 11.86% 12.32% 0.93% 6.21% 9.56% 10.43%
Lipper Category Avg. Small-Cap Growth Funds 11.71% 15.09% 7.37% 6.31% 9.50% -
Russell 2000® Growth Index 13.55% 18.53% 6.10% 4.22% 8.83% -
w/ sales charge 5.45% 5.86% -1.04% 4.96% 8.91% 10.30%

Fund Expense Ratio :

Gross 0.94%

Net 0.94%

TEN LARGEST HOLDINGS as of 08/31/2023View Portfolio

Holding Assets
Remitly Global Inc 2.9%
Duolingo Inc 2.5%
Flywire Corp 2.2%
Glaukos Corp 2.2%
Global-e Online Ltd 2.1%
Lattice Semiconductor Corp 2.1%
Rambus Inc 1.9%
Krystal Biotech Inc 1.9%
TransMedics Group Inc 1.9%
Samsara Inc 1.8%

INVESTMENT TEAM

F. Thomas O'Halloran
F. Thomas O'Halloran, CFA, J.D.

Partner & Portfolio Manager

36 Years of Industry Experience

Matthew R. DeCicco
Matthew R. DeCicco, CFA

Partner & Director of Equities

23 Years of Industry Experience

Vernon Bice
Vernon Bice, CMT

Portfolio Manager

22 Years of Industry Experience

Benjamin Ebel
Benjamin Ebel

Portfolio Manager

31 Years of Industry Experience

Supported By 10 Investment Professionals with 16 Years Avg. Industry Experience

Your Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

Fund Expense Ratio :

Gross 0.94%

Net 0.94%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 10/10/1973
w/o sales charge 5.49% -3.09% -4.92% 2.53% 8.04% 10.26%
Lipper Category Avg. Small-Cap Growth Funds 11.58% 6.74% 3.41% 4.51% 8.90% -
Russell 2000® Growth Index 12.68% 6.78% 2.67% 2.46% 8.17% -
w/ sales charge -0.56% -8.68% -6.79% 1.33% 7.40% 10.13%

Fund Expense Ratio :

Gross 0.94%

Net 0.94%

Fund Expense Ratio :

Gross 0.94%

Net 0.94%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 10/10/1973
w/o sales charge 11.86% 12.32% 0.93% 6.21% 9.56% 10.43%
Lipper Category Avg. Small-Cap Growth Funds 11.71% 15.09% 7.37% 6.31% 9.50% -
Russell 2000® Growth Index 13.55% 18.53% 6.10% 4.22% 8.83% -
w/ sales charge 5.45% 5.86% -1.04% 4.96% 8.91% 10.30%

Fund Expense Ratio :

Gross 0.94%

Net 0.94%

Year Fund Returns Russell 2000® Growth Index
2022 -36.09% -26.36%
2021 -2.66% 2.83%
2020 72.57% 34.63%
2019 31.91% 28.48%
2018 5.09% -9.31%
2017 29.92% 22.17%
2016 -2.71% 11.32%
2015 -8.90% -1.38%
2014 3.25% 5.60%
2013 57.19% 43.30%
2012 10.39% -
2011 -1.66% -
2010 36.54% -
2009 47.03% -
2008 -47.50% -
2007 35.83% -
2006 12.45% -
2005 11.87% -
2004 6.00% -
2003 40.06% -
Year Q1 Q2 Q3 Q4 Yearly Returns
2023 8.32% 3.27% - - -5.19%
2022 -19.27% -21.16% 0.59% -0.18% -36.09%
2021 1.64% 2.87% -3.66% -3.35% -2.66%
2020 -16.91% 40.59% 15.92% 27.45% 72.57%
2019 27.01% 9.09% -11.35% 7.39% 31.91%
2018 7.16% 14.97% 12.18% -23.96% 5.09%
2017 8.36% 4.06% 7.07% 7.61% 29.92%
2016 -10.30% 2.24% 10.87% -4.32% -2.71%
2015 7.12% 2.61% -15.70% -1.68% -8.90%
2014 1.67% 0.15% -5.75% 7.59% 3.25%
2013 13.50% 10.00% 18.78% 6.00% 57.19%
2012 12.16% -2.68% 5.55% -4.19% 10.39%
2011 10.23% 1.49% -20.86% 11.06% -1.66%
2010 8.21% -7.94% 16.47% 17.68% 36.54%
2009 -2.17% 24.37% 14.25% 5.76% 47.03%
2008 -21.82% 6.65% -11.81% -28.60% -47.50%
2007 4.65% 13.60% 9.82% 4.04% 35.83%
2006 15.98% -6.23% -6.80% 10.93% 12.45%
2005 -5.91% 5.82% 9.60% 2.52% 11.87%
2004 2.00% 0.20% -7.05% 11.58% 6.00%
2003 -3.27% 21.33% 9.79% 8.70% 40.06%
2002 0.07% -11.90% -23.81% 4.90% -29.54%
2001 -17.44% 16.01% -22.68% 25.62% -6.98%
2000 3.52% -13.67% -0.56% -7.37% -17.69%
1999 1.42% 11.69% -3.37% 26.23% 38.16%
1998 11.49% -2.94% -22.00% 28.29% 8.27%
1997 -2.88% 17.68% 21.77% -6.03% 30.78%
1996 8.18% 8.18% -2.85% 7.46% 22.19%
1995 6.04% 19.02% 15.90% -0.42% 45.66%
1994 0.16% -8.07% 10.54% 4.34% 6.20%
1993 -0.67% 1.03% 8.15% 3.76% 12.62%
1992 -2.92% -13.34% 5.39% 9.32% -3.06%
1991 29.96% -5.07% 9.77% 15.46% 56.36%
1990 1.18% 11.38% -24.62% 10.17% -6.41%
1989 3.04% 1.70% 8.07% 0.77% 14.12%
1988 8.71% 2.49% -4.04% -3.23% 3.45%
1987 23.22% -1.54% 5.33% -21.15% 0.76%
1986 12.02% 1.82% -18.44% 7.95% 0.42%
1985 9.91% -2.42% -9.28% 18.16% 14.96%
1984 -15.56% -5.27% 1.63% -4.54% -22.39%
1983 19.37% 16.69% -4.44% -6.33% 24.68%
1982 -11.29% 1.28% 11.66% 29.18% 29.58%
1981 6.38% 7.72% -18.09% 14.79% 7.74%
1980 -8.32% 13.37% 24.22% 5.17% 35.80%
1979 11.23% 3.38% 10.21% 1.23% 28.29%
1978 12.74% 18.50% 11.85% -9.31% 35.51%
1977 -5.21% 6.36% 3.99% 7.90% 13.12%
1976 25.90% -5.36% -5.21% 5.87% 19.57%
1975 36.09% 17.79% -12.76% -0.65% 38.93%
1974 2.02% -14.31% -23.96% -3.25% -35.69%
1973 - - - - -9.00%

Growth of $10,000 as of 08/31/2023

NAV Historical Prices

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioning as of 03/31/2023

  • The Fund is designed and managed to provide investors with access to the most innovative, high-growth companies in their respective industries. Our investment research process is iterative and continuous and includes three primary components: 1) identifying innovators and superior businesses, 2) assessing and quantifying operating momentum, and 3) assessing and quantifying stock price momentum
  • Our positive view of the market was tested in March amid turmoil within the regional banking industry. In particular, the failure of Silicon Valley Bank was challenging given its outsized role financing innovation companies. While we work to better understand the medium-term implications, we believe there will likely be a bifurcation between companies that receive funding, and those that do not. Speculative business models with less tangible proof-of-concept products will likely come under pressure, while higher-quality, innovative companies with unique value propositions and strong management teams will continue to receive funding and potentially extend their market shares. This may, in turn, lead to a shortage in initial public offerings in the coming years, which could further solidify the competitive moats of these higher-quality businesses.
  • On the monetary front, we expect the Fed to pause its rate hiking cycle soon, although this remains contingent on inflation and labor reports moderating as the Fed clearly remains “data dependent.” We believe a Fed pause, not necessarily a cut, is enough of a positive catalyst for the markets as it removes the key headwind to growth stocks over the past year. Overall, we believe a neutral central bank and moderating inflation creates a strong backdrop for equities - particularly for quality market leaders within the growth sectors that our strategies specialize in. Lastly, from a technical standpoint, indices have largely tested and held key levels so we continue to lean positive, understanding the macro backdrop remains, at minimum, uncertain. We are especially encouraged by the Nasdaq Composite’s technical profile, as the most recent “flight to quality” trade resulted in mega-cap tech outperforming the broader market.
  • With an uncertain macro backdrop likely to persist, we remain focused on companies that possess quality business models (i.e., high moats, high margins, and great balance sheets), as well as both positive operating and price momentum.  As such, over the quarter, we continued to add to our favorite growth names with idiosyncratic secular drivers that are less impacted by current macro headwinds – primarily within areas such as fintech, communication services, technology, and healthcare. We also reduced risk where prudent, cutting positions in companies that will require near-term funding, as well as positions in areas that are most vulnerable to the regional bank fallout and/or higher market volatility. Looking ahead, as interest rates and inflation potentially become secondary to fundamentals, we see increased opportunities for alpha generation. Many innovative companies faced dramatic valuation compression over the last two years and we believe many of these companies are now offering attractive risk/reward profiles. We also continue to expect communications services, consumer discretionary, small- and mid-cap health care, select industrials, and technology to lead the market higher

Dividends & Cap Gains

Dividends & Cap Gains

Dividend Payments

For
YTD Dividends Paidas of 09/26/2023
$0
Dividend Frequency
Annually
Record Date Ex-Dividend Date Reinvest & Payable Date Dividend Reinvest Price
02/14/1997 02/18/1997 03/03/1997 $0.00000

Upcoming Dividend Payment Dates

This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date Reinvest & Payable Date
11/20/2023 11/21/2023 11/21/2023

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
11/22/2021 11/23/2021 $3.3406 - $3.3406 $27.44

Fees & Expenses

Fees & Expenses

Sales Charge Schedule as of 09/26/2023

  Sales Charge Dealer's Concession Prices at Breakpoint
Less than $50,000 5.75% 5.00% $17.05
$50,000 to $99,999 4.75% 4.00% $16.87
$100,000 to $249,999 3.95% 3.25% $16.73
$250,000 to $499,999 2.75% 2.25% $16.52
$500,000 to $999,999 1.95% 1.75% $16.39
$1,000,000 to $5,000,000 0.00% 1.00% $16.07

Expense Ratioas of 08/31/2023

Fund Gross Expense Ratio Fund Net Expense Ratio
0.94% 0.94%

Fund Documents

Fund Documents

0Documents selected
Portfolio Holdings 1Q
Publish Date:11/03/2015
Portfolio Holdings 3Q
Publish Date:11/03/2015
Summary Prospectus
Publish Date:11/03/2015
Statutory Prospectus
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Commentary
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

The Russell 2000® Growth Index measures the performance of those Russell 2000 companies with higher price-to-book ratios and higher forecasted growth values.

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field